Status:
WITHDRAWN
Capturing Infectious COVID-19 Asymptomatic Cases in Singapore
Lead Sponsor:
Becton, Dickinson and Company
Conditions:
Covid19
SARS CoV-2
Eligibility:
All Genders
21+ years
Brief Summary
This study is being conducted to assess the performance of the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2, used in serial testing, in identification of infectious, asymptomatic individu...
Detailed Description
This multi-center, prospective, observational, diagnostic evaluation study is designed to assess the performance of the BD Veritor System in the detection of SARS-CoV-2 in asymptomatic individuals com...
Eligibility Criteria
Inclusion
- Male or female ≥21 years of age at the time of informed consent
- Has a positive screening test for SARS-CoV-2 by RT-PCR
- Is asymptomatic for COVID-19 on the day of their positive screening test (may have symptoms on the actual day of study enrollment)
- Is expected to remain at the study site for the full 6-day study period
- Willing and able to complete all study required procedures
- Provision of signed and dated informed consent form
Exclusion
- History of frequent or difficult to control nosebleeds within the 14 days prior to study participation
- If, at the discretion of the Investigator, involvement in the study is likely to jeopardize the subject's health or their current or future medical treatment
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 1 2021
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04812327
Start Date
June 1 2021
End Date
November 1 2021
Last Update
August 11 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Changi General Hospital
Singapore, Singapore